TD Waterhouse Canada Inc. Cuts Position in CME Group Inc. $CME

TD Waterhouse Canada Inc. lowered its position in shares of CME Group Inc. (NASDAQ:CME) by 54.2% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 12,468 shares of the financial services provider’s stock after selling 14,738 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in CME Group were worth $3,322,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Empowered Funds LLC lifted its position in CME Group by 11.5% during the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock valued at $2,660,000 after buying an additional 1,037 shares in the last quarter. Capital Investment Advisors LLC acquired a new position in shares of CME Group during the 2nd quarter valued at $211,000. Truist Financial Corp boosted its position in CME Group by 10.0% during the 2nd quarter. Truist Financial Corp now owns 64,939 shares of the financial services provider’s stock worth $17,898,000 after purchasing an additional 5,914 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its holdings in CME Group by 22.4% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 81,446 shares of the financial services provider’s stock valued at $22,448,000 after purchasing an additional 14,921 shares in the last quarter. Finally, Exchange Capital Management Inc. increased its holdings in CME Group by 1.4% in the 2nd quarter. Exchange Capital Management Inc. now owns 3,771 shares of the financial services provider’s stock valued at $1,039,000 after purchasing an additional 52 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME opened at $289.06 on Friday. The firm has a market cap of $104.24 billion, a price-to-earnings ratio of 28.01, a PEG ratio of 3.26 and a beta of 0.27. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The business’s 50 day moving average is $275.25 and its two-hundred day moving average is $272.33. CME Group Inc. has a 52-week low of $233.66 and a 52-week high of $291.76.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th were paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date was Friday, December 12th. CME Group’s dividend payout ratio is 48.45%.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Argus reduced their price objective on CME Group from $308.00 to $295.00 in a research note on Friday, October 31st. Jefferies Financial Group reduced their price target on CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a research report on Monday, January 12th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of CME Group from $310.00 to $318.00 and gave the company a “buy” rating in a research report on Wednesday, December 17th. Keefe, Bruyette & Woods boosted their target price on shares of CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a research report on Monday, October 13th. Finally, Weiss Ratings reaffirmed a “buy (b+)” rating on shares of CME Group in a report on Monday, December 29th. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $292.18.

Insiders Place Their Bets

In other news, CEO Terrence A. Duffy sold 25,000 shares of the stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the transaction, the chief executive officer owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. This trade represents a 27.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the sale, the director directly owned 1,091 shares of the company’s stock, valued at approximately $287,511.23. This represents a 47.82% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.30% of the stock is owned by company insiders.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.